Literature DB >> 8869717

The role of angiogenic factor bFGF in the development of dural AVFs.

T Terada1, M Tsuura, N Komai, R T Higashida, V V Halbach, C F Dowd, C B Wilson, G B Hieshima.   

Abstract

PURPOSE: Dural arteriovenous fistulas (dAVFs) are known to be acquired disorders. Angiogenic stimulants, such as basic fibroblast growth factor (bFGF), may be involved in the evolution of this disorder. We examined the appearance and localization of bFGF, in human dAVF sinuses, versus a control using immunohistochemical techniques, to evaluate these qualitative differences. PATIENTS AND METHODS: Four human dural sinuses from dAVF patients, and one control dural sinus were removed at surgery or autopsy and used for this study. Immunohistochemistry for bFGF was performed in all five specimens to identify its appearance and localization. Immunohistochemistry for alpha smooth muscle actin, factor VII related antigen, and macrophage (CD-68) were done in all tissues to identify the bFGF positive cell types.
RESULTS: In the control dural sinus, there was negative staining by bFGF immunohistochemistry. However, in all four sinuses of the dAVF patients, smooth muscle cells, endothelial cells, and meningeal cells were stained positively in various degrees by bFGF immunohistochemistry.
CONCLUSION: bFGF may be significant in the development of dAVFs, judging from its strong immunoreactivity in the sinuses of dAVF patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869717     DOI: 10.1007/bf01411267

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  23 in total

1.  Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study.

Authors:  M Hoshimaru; J A Takahashi; H Kikuchi; I Nagata; M Hatanaka
Journal:  J Neurosurg       Date:  1991-08       Impact factor: 5.115

Review 2.  Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells.

Authors:  D Gospodarowicz; G Neufeld; L Schweigerer
Journal:  Cell Differ       Date:  1986-07

3.  Monoclonal antibodies against human basic fibroblast growth factor.

Authors:  M Seno; M Iwane; R Sasada; N Moriya; T Kurokawa; K Igarashi
Journal:  Hybridoma       Date:  1989-04

4.  Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas.

Authors:  J A Takahashi; M Fukumoto; K Igarashi; Y Oda; H Kikuchi; M Hatanaka
Journal:  J Neurosurg       Date:  1992-05       Impact factor: 5.115

5.  Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.

Authors:  D Zagzag; D C Miller; Y Sato; D B Rifkin; D E Burstein
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

6.  HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization.

Authors:  T Tsukada; D Tippens; D Gordon; R Ross; A M Gown
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

7.  Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. A putative in vivo mechanism for autocrine growth.

Authors:  J M Miano; N Vlasic; R R Tota; M B Stemerman
Journal:  Arterioscler Thromb       Date:  1993-02

8.  Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells.

Authors:  D Gospodarowicz; N Ferrara; T Haaparanta; G Neufeld
Journal:  Eur J Cell Biol       Date:  1988-04       Impact factor: 4.492

9.  Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells.

Authors:  V Baldin; A M Roman; I Bosc-Bierne; F Amalric; G Bouche
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

Review 10.  Recent developments in the cell biology of basic fibroblast growth factor.

Authors:  D B Rifkin; D Moscatelli
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  10 in total

1.  Development of indirect cavernous dural arteriovenous fistula after trapping for direct carotid cavernous fistula. A case report.

Authors:  H Yoshino; H Ishihara; F Oka; S Kato; M Suzuki
Journal:  Interv Neuroradiol       Date:  2011-04-29       Impact factor: 1.610

2.  Multiple dural arteriovenous fistulas. Radiologic progression and endovascular cure. Case report.

Authors:  A J P Goddard; M S Khangure
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

3.  Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study.

Authors:  Joachim Klisch; Ralf Kubalek; Kai M Scheufler; Ute Zirrgiebel; Joachim Drevs; Martin Schumacher
Journal:  Neuroradiology       Date:  2005-01-14       Impact factor: 2.804

4.  Mechanism of the formation of dural arteriovenous fistula: the role of the emissary vein.

Authors:  E S Miyachi; T Izumi; N Matsubara; T Naito; K Haraguchi; T Wakabayashi
Journal:  Interv Neuroradiol       Date:  2011-06-20       Impact factor: 1.610

5.  Pathophysiology and classification of intracranial and spinal dural AVF.

Authors:  Sook Young Sim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2022-04-21

6.  Relationship between diabetes mellitus with dural arteriovenous fistula.

Authors:  Dong-Geun Lee; Lin Bo Zhao; Jae Ho Shim; Deok Hee Lee; Dae Chul Suh
Journal:  Neuroradiology       Date:  2013-06-28       Impact factor: 2.804

7.  Surgical management of dural arteriovenous fistulas with transosseous arterial feeders involving the jugular bulb.

Authors:  W Tirakotai; L Benes; C Kappus; U Sure; A Farhoud; S Bien; H Bertalanffy
Journal:  Neurosurg Rev       Date:  2006-11-16       Impact factor: 3.042

8.  Variations and management for patients with craniocervical junction arteriovenous fistulas: Comparison of dural, radicular, and epidural arteriovenous fistulas.

Authors:  Shunji Matsubara; Hiroyuki Toi; Hiroki Takai; Yuko Miyazaki; Keita Kinoshita; Yoshihiro Sunada; Shodai Yamada; Yoshifumi Tao; Noriya Enomoto; Yukari Ogawa Minami; Satoshi Hirai; Kenji Yagi; Hiroyuki Nakashima; Masaaki Uno
Journal:  Surg Neurol Int       Date:  2021-08-16

Review 9.  New insight into DAVF pathology-Clues from meningeal immunity.

Authors:  Tianqi Tu; Zhenghong Peng; Zihao Song; Yongjie Ma; Hongqi Zhang
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

Review 10.  Acquired pial and dural arteriovenous fistulae following superior sagittal sinus thrombosis in patients with protein S deficiency: a report of two cases.

Authors:  Shunji Matsubara; Koichi Satoh; Junichiro Satomi; Toshio Shigekiyo; Tomoya Kinouchi; Hajimu Miyake; Shinji Nagahiro
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-10-25       Impact factor: 1.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.